Marko Marinic elected to board of directors as Lay Member

Marko Marinic elected to board of directors as Lay Member

The World Federation of Hemophilia (WFH) is very pleased to announce that Marko Marinic was re-elected as a Lay Member during the WFH Annual Meeting of the General Assembly at the WFH 2026 World Congress on April 19, 2026.

Also available in: Français Español

Marko Marinic brings years of leadership experience with the WFH to his new role, most recently as a Lay Member from 2022 to 2026.

Marinic is a person with severe hemophilia A with inhibitors. He has been President of the Croatian Haemophilia Society since 2017, and a member of the Board of Directors of the WFH since 2022. He is a scientific advisor at the Ivo Pilar Institute of Social Sciences in Zagreb, Croatia. His research area is the quality of life of people with disabilities, quality of life of people with rare diseases, and bioethical issues. The topic of his doctoral dissertation was the value of human life in contemporary society. He is also an assistant professor at the University of Zagreb, a leader or collaborator on numerous scientific projects, the author of three books and more than 60 scientific papers, book chapters, congress presentations, etc.

Marko Marinic’s invaluable experience will continue to be a great asset to the WFH as a Lay Member.

To find out more about WFH governance and the WFH Board of Directors, please click here.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.